Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
CTHRC1: a serum biomarker for a pathological fibroblast in IPF.
Journal: Thorax
Published: May 28, 2026
Correction: ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation.
Journal: Oncotarget
Published: November 01, 2019
ABL kinase inhibition promotes lung regeneration through expansion of an SCGB1A1+ SPC+ cell population following bacterial pneumonia.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 19, 2019
Multifunctional Abl kinases in health and disease.
Journal: Journal of cell science
Published: January 06, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026